[
  {
    "ts": null,
    "headline": "Gilead stock falls on report of HIV prevention cuts",
    "summary": "Shares of Gilead Sciences (GILD) fell 2% on Wednesday following a Wall Street Journal report that the Trump administration is considering making cuts to domestic HIV prevention efforts. Yahoo Finance Health Reporter Anjalee Khemlani discusses the latest in the video above. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.",
    "url": "https://finnhub.io/api/news?id=9db08c0e5a57852932e2d6feac016a18c67d0ad86358a71d2eeb69ea93af8ef1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742419384,
      "headline": "Gilead stock falls on report of HIV prevention cuts",
      "id": 133325390,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Shares of Gilead Sciences (GILD) fell 2% on Wednesday following a Wall Street Journal report that the Trump administration is considering making cuts to domestic HIV prevention efforts. Yahoo Finance Health Reporter Anjalee Khemlani discusses the latest in the video above. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.",
      "url": "https://finnhub.io/api/news?id=9db08c0e5a57852932e2d6feac016a18c67d0ad86358a71d2eeb69ea93af8ef1"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Moved the Most Today: Nvidia, Tesla, Boeing, Autodesk, Gilead, Signet, Williams-Sonoma, and More",
    "summary": "Nvidia stock rises after the chip maker makes a number of product announcements at its annual AI GTC conference, Tesla trades higher after sharp slumps earlier this week, and Boeing’s chief financial officer says the company doesn’t see a material near-term impact from tariffs on its supply chain.",
    "url": "https://finnhub.io/api/news?id=52dafb64ff180a7e5bb046311960ce0ec5c0481b0452ee25e005f1ee2e5950b0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742417220,
      "headline": "These Stocks Moved the Most Today: Nvidia, Tesla, Boeing, Autodesk, Gilead, Signet, Williams-Sonoma, and More",
      "id": 133325391,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Nvidia stock rises after the chip maker makes a number of product announcements at its annual AI GTC conference, Tesla trades higher after sharp slumps earlier this week, and Boeing’s chief financial officer says the company doesn’t see a material near-term impact from tariffs on its supply chain.",
      "url": "https://finnhub.io/api/news?id=52dafb64ff180a7e5bb046311960ce0ec5c0481b0452ee25e005f1ee2e5950b0"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Dives As HHS Reportedly Mulls Cutting HIV Prevention Funding",
    "summary": "Gilead stock tumbled Wednesday on reports HHS could slash federal funding for HIV prevention, a staple in Gilead Sciences' topline.",
    "url": "https://finnhub.io/api/news?id=b8e93c58fd60539827ab4cc3e92131c693bdab64181a2b0bef867820e29f3e85",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742414525,
      "headline": "Gilead Dives As HHS Reportedly Mulls Cutting HIV Prevention Funding",
      "id": 133325392,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead stock tumbled Wednesday on reports HHS could slash federal funding for HIV prevention, a staple in Gilead Sciences' topline.",
      "url": "https://finnhub.io/api/news?id=b8e93c58fd60539827ab4cc3e92131c693bdab64181a2b0bef867820e29f3e85"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street weighs in on Gilead as shares fall on possible U.S. HIV cuts",
    "summary": "Investing.com -- Gilead Sciences shares dropped more than 3% Wednesday following a Wall Street Journal report that the Health and Human Services Department is considering major cuts to federal funding for domestic HIV prevention programs.",
    "url": "https://finnhub.io/api/news?id=20db17cbd76d25f8f828e5eb250ce2ee9b343a19ad42c09b4ed4a098f9339a41",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742409153,
      "headline": "Wall Street weighs in on Gilead as shares fall on possible U.S. HIV cuts",
      "id": 133325393,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Investing.com -- Gilead Sciences shares dropped more than 3% Wednesday following a Wall Street Journal report that the Health and Human Services Department is considering major cuts to federal funding for domestic HIV prevention programs.",
      "url": "https://finnhub.io/api/news?id=20db17cbd76d25f8f828e5eb250ce2ee9b343a19ad42c09b4ed4a098f9339a41"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to Watch Wednesday: Nvidia, Shopify, Williams-Sonoma, Tesla",
    "summary": "↘️ Gilead Sciences (GILD): The Trump administration is weighing plans to slash funding for HIV prevention; such cuts could affect drugmakers Gilead and Viiv Healthcare. Gilead stock fell Wednesday afternoon, as did shares in GSK (GSK), the majority owner of ViiV.",
    "url": "https://finnhub.io/api/news?id=ccd80427d35d885f6236b42b59c4624d55fef1cc40b5298c599c3d42a0f953c7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742399117,
      "headline": "Stocks to Watch Wednesday: Nvidia, Shopify, Williams-Sonoma, Tesla",
      "id": 133325394,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "↘️ Gilead Sciences (GILD): The Trump administration is weighing plans to slash funding for HIV prevention; such cuts could affect drugmakers Gilead and Viiv Healthcare. Gilead stock fell Wednesday afternoon, as did shares in GSK (GSK), the majority owner of ViiV.",
      "url": "https://finnhub.io/api/news?id=ccd80427d35d885f6236b42b59c4624d55fef1cc40b5298c599c3d42a0f953c7"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences Should Not See Any Impact From HIV-Related Cost Reductions at US Healthcare Department, Truist Says",
    "summary": "Gilead Sciences (GILD) should not see any impact from the reported cost reductions at the US Departm",
    "url": "https://finnhub.io/api/news?id=c2f1d2d3ee584644f7d343737aa6958e62d32c52198950a0317fa4c0bfc5714a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742397630,
      "headline": "Gilead Sciences Should Not See Any Impact From HIV-Related Cost Reductions at US Healthcare Department, Truist Says",
      "id": 133325395,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences (GILD) should not see any impact from the reported cost reductions at the US Departm",
      "url": "https://finnhub.io/api/news?id=c2f1d2d3ee584644f7d343737aa6958e62d32c52198950a0317fa4c0bfc5714a"
    }
  },
  {
    "ts": null,
    "headline": "FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review",
    "summary": "Dr. Reddy and Alvotech announce the FDA acceptance of the BLA for their proposed biosimilar candidate of Amgen's Prolia and Xgeva for review.",
    "url": "https://finnhub.io/api/news?id=680e92563ff55e9cf92e684f269a9a0f0ecfe386216b43ca15b520979fde53b7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742397180,
      "headline": "FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review",
      "id": 133325059,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Dr. Reddy and Alvotech announce the FDA acceptance of the BLA for their proposed biosimilar candidate of Amgen's Prolia and Xgeva for review.",
      "url": "https://finnhub.io/api/news?id=680e92563ff55e9cf92e684f269a9a0f0ecfe386216b43ca15b520979fde53b7"
    }
  },
  {
    "ts": null,
    "headline": "HIV Drug Makers Get Spooked by Possible Trump Cut, but Impact Looks Manageable",
    "summary": "Gilead Sciences has been one of the best-performing large biotech companies over the past year, rising about 50%.  Shares of both Gilead and GSK, another HIV-focused drugmaker, fell after The Wall Street Journal reported the administration was considering drastic cuts to funding for domestic HIV prevention.  Perhaps more important is that the potential cuts come as investors are increasingly worried about broader potential reductions to Medicaid, which could impact access to HIV drugs.",
    "url": "https://finnhub.io/api/news?id=3c500758261e3840bb7eedbc6170ea97c0e4494b22588a6e153164d5ef9b5514",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742395802,
      "headline": "HIV Drug Makers Get Spooked by Possible Trump Cut, but Impact Looks Manageable",
      "id": 133325397,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences has been one of the best-performing large biotech companies over the past year, rising about 50%.  Shares of both Gilead and GSK, another HIV-focused drugmaker, fell after The Wall Street Journal reported the administration was considering drastic cuts to funding for domestic HIV prevention.  Perhaps more important is that the potential cuts come as investors are increasingly worried about broader potential reductions to Medicaid, which could impact access to HIV drugs.",
      "url": "https://finnhub.io/api/news?id=3c500758261e3840bb7eedbc6170ea97c0e4494b22588a6e153164d5ef9b5514"
    }
  },
  {
    "ts": null,
    "headline": "Why Gilead Sciences (GILD) Is Among the Most Undervalued Biotech Stocks to Invest In",
    "summary": "We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against the other most undervalued biotech stocks to invest in. Trump’s Tariffs and the Pharma Sector On February 21, Jared Holz, Mizuho Securities […]",
    "url": "https://finnhub.io/api/news?id=7189a8614ea27802142d62c7be933d9c01916411c0ba9f3d5c955ff30c386dd1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742394732,
      "headline": "Why Gilead Sciences (GILD) Is Among the Most Undervalued Biotech Stocks to Invest In",
      "id": 133325398,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against the other most undervalued biotech stocks to invest in. Trump’s Tariffs and the Pharma Sector On February 21, Jared Holz, Mizuho Securities […]",
      "url": "https://finnhub.io/api/news?id=7189a8614ea27802142d62c7be933d9c01916411c0ba9f3d5c955ff30c386dd1"
    }
  },
  {
    "ts": null,
    "headline": "Buy 3 U.S. Giants Flying High Year to Date Defying Severe Volatility",
    "summary": "Three U.S. bigwigs flying high year to date with more upside are GILD, GE and PGR.",
    "url": "https://finnhub.io/api/news?id=4823552375ad14ba3b6d9bb7a56f6bca53185eac3866dc58365fa9f0e57901a0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742393220,
      "headline": "Buy 3 U.S. Giants Flying High Year to Date Defying Severe Volatility",
      "id": 133321655,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Three U.S. bigwigs flying high year to date with more upside are GILD, GE and PGR.",
      "url": "https://finnhub.io/api/news?id=4823552375ad14ba3b6d9bb7a56f6bca53185eac3866dc58365fa9f0e57901a0"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Stock Falls on Report Trump Administration Wants to Cut HIV-Prevention Funding",
    "summary": "Gilead Sciences  stock declined Wednesday after The Wall Street Journal reported the Department of Health and Human Services was considering federal funding cuts to domestic HIV prevention.  The Centers for Disease Control and Prevention, an arm of the HHS, has a Division of HIV Prevention dating back to the 1980s.  In addition to tracking HIV infections across the country, it focuses on community outreach, working with state and local leaders to promote testing and prevention.",
    "url": "https://finnhub.io/api/news?id=1a910fd9b3958e35d079791d02374f968e69da2219215536abca834aa309f617",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742392800,
      "headline": "Gilead Stock Falls on Report Trump Administration Wants to Cut HIV-Prevention Funding",
      "id": 133325400,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences  stock declined Wednesday after The Wall Street Journal reported the Department of Health and Human Services was considering federal funding cuts to domestic HIV prevention.  The Centers for Disease Control and Prevention, an arm of the HHS, has a Division of HIV Prevention dating back to the 1980s.  In addition to tracking HIV infections across the country, it focuses on community outreach, working with state and local leaders to promote testing and prevention.",
      "url": "https://finnhub.io/api/news?id=1a910fd9b3958e35d079791d02374f968e69da2219215536abca834aa309f617"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Roundup: Market Talk",
    "summary": "Health Care Roundup: Market Talk",
    "url": "https://finnhub.io/api/news?id=dcdf6a2e893a55de2f10dc41ca63cf518f91ab21712c8d5481f7205d264c3d6f",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742387340,
      "headline": "Health Care Roundup: Market Talk",
      "id": 133267051,
      "image": "",
      "related": "GILD",
      "source": "DowJones",
      "summary": "Health Care Roundup: Market Talk",
      "url": "https://finnhub.io/api/news?id=dcdf6a2e893a55de2f10dc41ca63cf518f91ab21712c8d5481f7205d264c3d6f"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Are Moving the Most Today: Nvidia, Tesla, Autodesk, General Mills, Signet, HealthEquity, and More",
    "summary": "These Stocks Are Moving the Most Today: Nvidia, Tesla, Autodesk, General Mills, Signet, HealthEquity, and More",
    "url": "https://finnhub.io/api/news?id=2a0985dadcf68508687f639d547c84ae4d29208bda6e7afefebcd028c017b92d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742369160,
      "headline": "These Stocks Are Moving the Most Today: Nvidia, Tesla, Autodesk, General Mills, Signet, HealthEquity, and More",
      "id": 133240129,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "These Stocks Are Moving the Most Today: Nvidia, Tesla, Autodesk, General Mills, Signet, HealthEquity, and More",
      "url": "https://finnhub.io/api/news?id=2a0985dadcf68508687f639d547c84ae4d29208bda6e7afefebcd028c017b92d"
    }
  }
]